This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
All available integrated interventional radiology resident positions were filled, and a vast majority (97.4%) of diagnostic radiology positions were filled on 2025 Main Residency Match Day, March 21. In nuclearmedicine, there were 13 applicants for PGY-2. In nuclearmedicine, there were 13 applicants for PGY-2.
Eliot Siegel, MD, of the University of Maryland shares his perspective on the rapidly emerging area of theranostics and the potential for interventional molecular radiology to join diagnostic radiology and interventional radiology as a third pathway for radiology and nuclearmedicine trainees.
He earned his medical degree at the University of Alabama School of Medicine and completed a residency in diagnostic radiology at the University of Florida. His area of expertise is neuroradiology, with a special emphasis on diagnostic imaging of the head, neck, brain, and spine. He served in the U.S. Elliot Fishman, MD.
The Society introduced a new slate of officers, and recognized new Fellows, during its SNMMI 2023 Annual Meeting , held June 24-27 in Chicago, IL. The potential impact of nuclearmedicine in the care of patients dealing with cancer, heart disease, brain disease, and other challenges is enormous,” she said. “We
in 2024 compared with 2023, according to the newly published IMV 2025 PET Market Summary Report. Follow IMV Medical Information on LinkedIn for more diagnostic imaging updates. Davin Korstjens is the Director of Market Intelligence at IMV Medical Information Division, part of Science and Medicine Group.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
Although falling just short of the 100% rate achieved in the last two years, nearly all available resident positions for diagnostic and interventional radiology were filled on Match Day 2024 on March 15. That’s up from 42,952 applicants and 40,375 residency positions in 2023. from the 48,156 applicants registered in last year’s match.
the RSNA Mahmood's primary research for the past 30 years has been in molecular imaging and its application to guide precision medicine. At MGH in Boston, he currently serves as chief of nuclearmedicine and molecular imaging, overseeing the service for multiple hospitals and facilities in the region. Umar Mahmood, MD, PhD.
Claude, and Google Bard monthly from November 2023 to January 2024, using multiple-choice practice questions from the ACR Diagnostic in Training Exam (DXIT) (n = 172). The researchers queried GPT-4, GPT-3.5, Overall, GPT-4 performed with highest average accuracy (76 %), followed by Google Bard (73%), Claude (71%), and GPT-3.5 (63%),
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. Interventional In image-guided surgery activities, GEHC showcased two new AI applications previously presented at ECR 2023.
Thomas Hope, MD, a radiologist and nuclearmedicine physician at the University of California, San Francisco (UCSF), said that approval of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand has driven a marked interest and excitement about theranostics and radioligand therapies (RLT). Hope added.
The Society of NuclearMedicine and Molecular Imaging (SNMMI) presented its 2025 Legislative Champion Award to Representatives Neal Dunn, MD, and Ami Bera, MD. Dunn (R-FL) helped push the U.S.
The Society of NuclearMedicine and Molecular Imaging (SNMMI) has declared an advocacy win, with language it crafted to promote nuclearmedicine research included in the recently approved 2024 Defense Appropriations Act. “In
The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclearmedicine, and radiation oncology. The proposal would include all "topped-out" diagnostic radiology measures (i.e., However, interventional radiology will have a decrease of 2%.
They then used archive files from 2021-2023 to calculate an attrition rate for those years and a cumulative attrition rate for 2021-2024. Emergency medicine physicians: 26.6% Medicine subspecialists: 12.9% Attrition among specialties was as follows: Average among all providers: 16.4% Primary care physicians: 17.5% Surgeons: 16.7%
CHICAGO – Gallium-68 (Ga-68) RM2-PET/MRI is better than MRI alone for detecting relapse in prostate cancer patients, according to research presented November 26 at RSNA 2023. You've hear a lot about PSMA. An image showing potentially different sites of PET radiotracer uptake by prostate cancer tumors between U.S.
By combining molecular imaging information with genomics, we have created a diagnostic technique that could be truly personalized for each patient. This has potential for broad diagnostic utility across many disease types, not only Alzheimer’s disease,” Dutta added. Thursday, June 29, 2023 - 12:45
Thiel and colleagues performed an LCA in April 2023 of the diagnostic radiology practice of Vanderbilt University Medical Center in Nashville, TN. "LCAs establish baseline data on carbon emissions and environmental waste and help analyze the impact of interventions on carbon footprints."
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.
This makes the Medicare payment rate 1.77% lower than it was in 2023, rather than the 3.37% cut that was contained in the 2024 MPFS Final Rule. decrease from 2023 in Mississippi, but it could have been an 8.5% from 2023 levels, based on the same volume of services. the “GPCI Work Floor”). wGPCI $ 7.95 -4.8% - 2024 with 0.95
Cathy Sue Cutler, PhD, has been named president of the Society of NuclearMedicine and Molecular Imaging (SNMMI). She also intends to create training and education opportunities in theranostics and to educate the public on nuclearmedicine and its value. Cutler's awards are many.
mtaschetta-millane Sat, 11/25/2023 - 06:00 November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting starting Sunday in Chicago, Illinois.
Due to their body shape, it’s often hard to image obese individuals,” said Krishna Patel, MD , assistant professor of medicine and cardiology at the Icahn School of Medicine At Mount Sinai in New York. This can result in inferior image quality and diagnostic performance despite requiring a higher dose of radiation.”
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
milla1cf Fri, 05/12/2023 - 22:07 May 12, 2023 — A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes. This research was published in the May issue of The Journal of NuclearMedicine.
Food and Drug Administration on May 25, 2023. POSLUMA is now commercially available through multiple radiopharmacies of PETNET Solutions, the primary manufacturer and commercial distributor for Blue Earth Diagnostics in the United States. Chief Executive Officer of Blue Earth Diagnostics Ltd. Gauden , D.Phil.,
NorthStar Medical Radioisotopes will shut down its molybdenum-99 (Mo-99) production facilities in Beloit, WI, by the end of 2023, citing increasing costs and competition, the company reported. said the Society of NuclearMedicine and Molecular Imaging (SNMMI).
mtaschetta-millane Sat, 06/24/2023 - 15:00 June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” ( AWSM-PET ) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging. Louis, Missouri.
milla1cf Wed, 10/11/2023 - 13:08 October 11, 2023 — A new imaging agent, 68Ga-ABY-025 , can predict early metabolic response to human epidermal growth factor receptor 2 ( HER2 )-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in the September issue of The Journal of NuclearMedicine.
The new slate of officers was introduced during the Society of NuclearMedicine and Molecular Imaging’s 2023 Annual Meeting, held June 24-27. “I I and am very passionate about supporting the nuclearmedicine technologist profession through advocacy and volunteerism.
and more faculty from the Society for NuclearMedicine ad Molecular Imaging (SNMMI) 2023 conference. Catch up on recent interviews with Jeremie Calais, M.D. MSc, Krishna Patel, M.D., Phillip Kuo, M.D.
milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of NuclearMedicine and Molecular Imaging (SNMMI).
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 Blue Earth Diagnostics received U.S.
mtaschetta-millane Sat, 06/24/2023 - 17:00 June 24, 2023 — A new ultra-high resolution (UHR) brain PET scanner may have the ability to characterize previously indistinguishable brain regions that are known to be involved in Alzheimer’s disease , depressive disorders, visual attention disorders, tinnitus, and other conditions.
christine.book Mon, 12/04/2023 - 11:29 December 4, 2023 — Ajay Gupta, MD, MS , has been named chair of the Department of Radiology at Columbia University Vagelos College of Physicians and Surgeons and radiologist-in-chief at NewYork-Presbyterian/CUIMC. More information: www.cuimc.columbia.edu Monday, December 4, 2023 - 11:29
milla1cf Mon, 06/24/2024 - 20:34 June 24, 2024 — The Radiological Society of North America ( RSNA ) announced the 2023 impact factors today for its suite of journals. Launched in 1981, RadioGraphics is one of the leading education journals in diagnostic radiology. Edited by Linda Moy , M.D., Radiology has an impact factor of 12.1.
percent for diagnosing clear cell renal cell carcinoma, according to research recently presented at the European Association of NuclearMedicine (EANM) 2023 Congress. For cT1 renal masses < 4 cm and renal masses < 2 cm, the PET/CT agent 89Zr-DFO-girentuximab had respective sensitivity rates of approximately 85 percent and 96.7
The agreement includes hundreds of new systems, including AI-enabled technologies , across nuclearmedicine , X-Ray , vascular and cardiovascular ultrasound , regional CT , fluoroscopy, surgery, and bone densitometry for which GE HealthCare will be the sole provider.
The findings suggest that use of the tool could "facilitate tracking and timely completion of clinically necessary recommendations for additional imaging and thereby potentially reduce diagnostic delays," wrote a team led by Kathryn Li of Brigham and Women's Hospital and Harvard Medical School, both in Boston. and GPT-4.
milla1cf Thu, 09/14/2023 - 15:17 September 14, 2023 — Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content